c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells

Elaine M Reno1, James M Haughian, Twila A Jackson

  • 1Department of Obstetrics and Gynecology, Section of Basic Reproductive Sciences, School of Medicine, University of Colorado Denver, Mail Stop 8309, 12800 E. 19th Avenue, Aurora, CO 80045, USA.

Insights

c-Jun N-terminal kinases (JNKs) and protein kinase C delta (PKCdelta) regulate apoptosis in endometrial cancer. Their activity influences sensitivity to chemotherapy, suggesting a tumor suppressor role.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • c-Jun N-terminal kinases (JNKs) are key regulators of cell proliferation and apoptosis, implicated in tumorigenesis.
  • Endometrial cancer presents distinct subtypes (Type I and Type II) with varying cellular mechanisms.

Purpose of the Study:

  • To investigate the role of JNKs in apoptotic responses in Type I (Ishikawa) and Type II (HEC-50) endometrial cancer cells.
  • To explore the interplay between JNK, MAP kinase kinase 4 (MKK4), and protein kinase C delta (PKCdelta) in regulating apoptosis and chemoresistance.

Main Methods:

  • Utilized etoposide treatment and UV irradiation to induce JNK activation and apoptosis in endometrial cancer cell lines.
  • Employed JNK and MKK4 inhibition, alongside PKCdelta knockdown, to assess their impact on apoptotic pathways.
  • Differentiated between stimulus-dependent and cell-type-specific signaling pathways.

Main Results:

  • Sustained JNK activation correlated with apoptosis induction following etoposide or UV treatment.
  • Inhibition of JNK or MKK4 selectively suppressed apoptosis in both cell types.
  • PKCdelta knockdown attenuated apoptosis and affected UV-mediated JNK activation in HEC-50 cells, but not Ishikawa cells, indicating stimulus and cell-type-specific roles.

Conclusions:

  • JNK regulates apoptosis via both PKCdelta-dependent and independent pathways, contingent on the stimulus and cell type.
  • JNK and PKCdelta expression and activity in endometrial cancer cells modulate apoptosis and chemosensitivity.
  • These kinases may function as tumor suppressors in endometrial cancer, impacting therapeutic strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...